$2.45
N/A
Last update: Nov 11, 9:25 AM
Rocket Pharmaceuticals Inc (RCKT) Stock Price, Quote, News & History
RCKTNASDAQ
Rocket Pharmaceuticals announces positive early safety results for its RP-A501 Phase 2 trial in Danon disease and plans further FDA talks.
You can purchase shares of Rocket Pharmaceuticals (NASDAQ:RCKT) through any online brokerage.
Other companies in Rocket Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Rocket Pharmaceuticals has a consensus price target of $8.77.
The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $2.45 last updated November 11, 2026 at 9:25 AM EST.
There are no upcoming dividends for Rocket Pharmaceuticals.
Rocket Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Rocket Pharmaceuticals.
Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for...
